Overview

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension

Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A comparison study of two combination drugs, amlodipine/benazepril and benazepril/HCTZ to evaluate the effectiveness of the combination on reducing heart disease and death in a high risk hypertensive population.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Antihypertensive Agents
Benazepril
Hydrochlorothiazide